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Abstract
Pneumococcal disease is associated with a particularly high morbidity and mortality amongst adults in HIV endemic
countries. Our previous findings implicating a B-cell defect in HIV-infected children from the same population led us to
comprehensively characterize B-cell subsets in minimally symptomatic HIV-infected Malawian adults and investigate the
isotype-switched IgG memory B-cell immune response to the pneumococcus. We show that similar to vertically acquired
HIV-infected Malawian children, horizontally acquired HIV infection in these adults is associated with IgM memory B-cell
(CD19+ CD27+ IgM+ IgD+) depletion, B-cell activation and impairment of specific IgG B-cell memory to a range of
pneumococcal proteins. Our data suggest that HIV infection affects both T-cell independent and T-cell dependent B-cell
maturation, potentially leading to impairment of humoral responses to extracellular pathogens such as the pneumococcus,
and thus leaving this population susceptible to invasive disease.
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Introduction
The burden of invasive pneumococcal disease (IPD) is high in
many African countries, including Malawi, where a high
prevalence of HIV infection is associated with increased rates
and severity of IPD in both adults and children [1,2,3].
Pneumonia, pneumococcal bloodstream infection and meningitis
amongst HIV-infected individuals are all common reasons for
adult hospital admissions in this setting [1,4]. In Malawian
children, we have previously demonstrated a shift in the B-cell
compartment toward an apoptosis-prone phenotype (CD19+
CD102 CD21lo) evident early in HIV disease progression,
associated with reduced numbers of pneumococcal protein
antigen–specific memory B-cells [5] which may in part explain
their susceptibility to IPD.
We have recently shown that even in asymptomatic HIV-
infected Malawian adults, pneumococcal-specific interferon–
gamma (IFN-c)-mediated CD4 T-cell effector memory and
CD4 T-cell central memory proliferative responses are impaired
[6]. An immune defect that does not fully resolve following
antiretroviral therapy (ART) [7]. In other settings, HIV-infected
adults with chronic infection or advanced disease have been
shown to have an over representation of apoptosis prone
immature transitional B-cells (CD10+ CD272) and mature
activated B-cells (CD102 CD21lo) [8,9,10]. The mature activated
B-cells have increased expression of CD95 and are notably
susceptible to CD95 ligand-mediated apoptosis, while the
immature transitional B-cells are notably susceptible to intrinsic
apoptosis, expressing very low levels of anti-apoptotic Bcl-2
proteins [8,9,10,11]. It is uncertain, however, whether these B-
cell defects occur in African adults or whether they impact on
antigen-specific immunity. We have therefore investigated
whether in comparison to children who have acquired HIV
perinatally (a critical time for the development of the B-cell
compartment), Malawian adults are equally susceptible to HIV-
mediated B-cell dysfunction. We comprehensively characterized
the B-cell subset profile of HIV-infected Malawian adults and
then investigated whether the dysregulation identified was




Otherwise healthy HIV-infected adults aged between 18 and 55
years old, with clinical features of WHO stage I were recruited
from the voluntary counselling & testing (VCT) and ART out-
patients clinics of Queen Elizabeth Central Hospital, Malawi
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following informed consent [12]. The volume of blood collected
from these adults ranged from 30 – 50 mL. All participants were
ART treatment naı¨ve. Healthy controls with no clinical features of
HIV were recruited by advertisement in the hospital. All controls
were counselled and written consent was sought for HIV testing.
HIV seropositivity was confirmed using two complementary HIV
rapid antibody tests UnigoldTM (Trinity Biotech, Ireland) and
DetermineTM (Abbott, Japan) according to manufacturers’
instructions. In the case of disparate results, a third test was
performed using Bioline test kit (Standard Diagnostics Inc, Korea).
Pregnant women were excluded from the study. None of the
participants received a pneumococcal vaccine. Nasopharyngeal
swabs were collected from study participants for the identification
of Streptococcus pneumoniae [13]. In order to exclude malaria as a
confounding factor in the immunological assays, all study
participants were tested for malaria. This study complies with
relevant guidelines and institutional practices of the Malawi-
Liverpool Wellcome Trust Clinical Research Programme and the
University of Malawi College of Medicine and was approved by
the College of Medicine Research Ethics Committee (P.03/08/
626).
Immunophenotyping
The proportions and absolute numbers of B- and T-cells were
estimated from EDTA whole blood samples by flow cytometry as
previously described [5]. Briefly, fluorescein isothiocyanate
(FITC)-labeled anti-CD19, and anti-CD21; phycoerythrin (PE)-
labeled anti-CD8, anti-CD27, and anti-IgD; peridinin chlorophyll
protein (PerCP)-labeled anti-CD3 and anti-CD19; and allophy-
cocyanin (APC)-labeled anti-CD4, anti-CD10, and anti-CD27
were used for comprehensive phenotyping in the flow cytometric
assays. A minimum of 100,000 events was acquired within the
lymphocyte gate using CellQuest Pro software on a 4-color flow
cytometer (BD FACSCalibur). Results were analysed using FlowJo
software, version 7.2.2 (Tree Star).
PBMC Enzyme-Linked Immunospot Assay
As previously described [5], memory B-cell numbers were
enumerated using an enzyme-linked immunospot (ELISPOT)
assay, following stimulation of freshly isolated peripheral blood
mononuclear cells (PBMCs) in culture for 6 days in the presence of
a combination of 1/100,000 standardized pansorbin cells (heat-
killed, formalin-fixed Staphylococcus aureus, Cowan 1 strain), 1 mg/
mL phosphothiolated CpG oligoneucleotide 2006 and 1/1000
pokeweed mitogen extract. This is an adaptation of the ELISPOT
method of Crotty and is a sensitive technique able to detect
antigen and isotype specific memory B-cells in peripheral blood
that has differentiated into antibody secreting cells in vitro [14].
Immune memory to Choline binding protein A – CbpA,
Pneumococcal surface protein A – PspA, Pneumolysin – Ply and
Pneumococcal surface antigen A – PsaA [15,16,17,18] was then
enumerated using the AID ELISPOT reader and analysis software
version 4.0 (AID).
Statistical Analysis
We performed statistical analysis using Stata (version 10) and
GraphPad Prism (version 4.0) software. Wilcoxon-Mann-Whitney
U-test was used to perform the comparison between HIV2 and
HIV+ adults. The Fisher’s exact test of probability was used for
categorical data. Data were expressed as median values and
interquartile ranges (IQR), and differences after comparisons were
considered statistically significant if P,0.05. The association
between two parameters was determined by Spearman’s correla-
tion using Stata.
Results
Baseline characteristics of the study participants
Forty three HIV+ adults (median age 37, IQR 27 – 42 years)
were recruited into the study and stratified into 2 groups
comprising 17 participants who had CD4+ counts .350cells/ml
(Group I) and 26 with CD4+ counts #350cells/ml (Group II), as
#350cells/ml was the accepted threshold for initiation of ART in
adults recommended by the WHO at the time of the study [12]. 44
HIV2 healthy control adults (median age 31, IQR 25 – 40 years)
were also recruited. Demographic characteristics of study partic-
ipants are shown in Table 1. Both CD19+ B-cell and CD4+ T-cell
counts & percentages were lower in HIV+ adults compared to
HIV2 controls. Also as expected, median CD8+ T-cell counts and
percentages were higher in the HIV+ group than the controls. As
we have previously observed in asymptomatic individuals [6],
there was no statistically significant difference observed between
pneumococcal carriage rates in HIV+ (7%) and HIV2 adults
(12%) (Table 1).
B-cell immunophenotype in HIV-infected adults
Consistent with our previous findings in children [5], both
mature naı¨ve (CD19+ CD102 CD272 CD21hi) and resting
memory (CD19+ CD27+ CD21hi) B-cells were depleted in
Malawian HIV+ adults, all of whom were in early stage disease
by clinical criteria (WHO clinical stage I) compared to HIV2
controls (Figure 1A-B). In addition, the proportions of apoptosis
prone mature activated (CD19+ CD21lo CD102) B-cells were
significantly higher in the HIV+ cohort (Figure 1C). Apoptosis
prone immature transitional (CD19+ CD10+ CD272) B-cells were
also significantly higher in HIV+ adults (Figure 1D). On stratifying
HIV+ adults into two groups based on their CD4+ counts,
depletion of resting memory B-cells was observed even in the
group with relatively preserved CD4+ counts (Group I). An over-
representation of mature activated B-cells was also evident in this
group (Group I, Figure 1). Although a depletion of mature naı¨ve
B-cells and over-representation of immature transitional B-cells
was observed in this group, it did not reach statistical significance
(Group I, Figure 1A and D).
The B-cell memory compartment was further investigated to
delineate changes associated with HIV infection. The median IgM
memory B-cell (CD19+ CD27+ IgD+) numbers and percentages in
HIV+ adults were significantly lower than in HIV2 controls
regardless of stratification (Figure 2A-B) and there was a moderate
correlation between these IgM memory B-cell parameters and
CD4+ T-cell numbers and percentages respectively (Figure 3).
However, the median absolute numbers and percentages of
peripheral blood isotype-switched memory B-cells (CD19+ CD27+
IgD2) in HIV+ adults was similar to that in HIV2 controls (Figure
2C-D).
Pneumococcal protein antigen specific immunoglobulin
G memory B-cells in the blood of HIV-infected adults
While IgM memory B-cells (directed largely against polysac-
charide) are thought to contribute to the first-line defense against
invasive disease caused by encapsulated bacteria, naturally
acquired isotype-switched IgG memory B-cells to protein antigens
are generally thought to be responsible for long-term serological
memory. This isotype-switched memory is dependent on T-cell
help, which we have previously shown to be defective in HIV-
infected adults [6,7].
We show that even though no decrease was observed in isotype-
switched IgG memory B-cell proportions and numbers in
Malawian HIV-infected adults, there was a functional impairment
Pneumococcal Immunity in HIV Infected Adults
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Table 1. Baseline demographic and immune parameters of HIV-infected and uninfected Malawian adult study participants.
HIV2 (n = 44) All HIV+ (n =43)
Significance of
difference between HIV2
and all HIV+ P values
HIV+ Group I CD4.350
(cell/ml) (n = 17)
HIV+ Group II CD4#350
(cell/ml) (n = 26)
Age, years 31 (25 – 40) 37 (27 – 42) P = 0.1 (ns) 39 (30 – 41) 36 (26 – 44)
Female (%) 19/44 (43) 25/43 (58) P = 0.2 (ns) 10/17 (59) 15/26 (58)
% CD4+ T cells 41.7 (34.7 – 45.9) 16.6 (9.1 – 24.5) P,0.0001 24.5 (18.7 – 28.0) 11.9 (7.3 – 16.6)
CD4+ T cell
count (cell/ml)
795 (662 – 927) 272 (154 – 442) P,0.0001 459 (403 – 648) 173 (95 – 272)
% CD8+ T cells 28.4 (23.8 – 32.3) 55.1 (45.5 – 61.2) P,0.0001 47.7 (38.5 – 55.9) 59.3 (47.3 – 65.7)
CD8+ T cell
count (cell/ml)
536 (427 – 687) 843 (547 – 1307) P = 0.0001 1041 (636 – 1234) 832 (526 – 1315)
% CD19+ B cells 9.8 (7.5 – 11.1) 7.6 (5.5 – 10.1) P = 0.01 6.8 (5.8 – 10.2) 7.9 (5.2 – 10.2)
CD19+ B cell
count (cell/ml)
189 (147 – 235) 116 (88 – 177) P = 0.001 134 (112 – 308) 105 (83 – 168)
Malaria (%) 1/44 (2) 0/43 (0) P = 0.9 (ns) 0/17 (0) 0/26 (0)
{ S. pneumoniae
carriage (%)
5/43 (12) 3/41 (7) P = 0.7 (ns) 0/17 (0) 3/24 (13)
Median and interquartile ranges (IQR) for age and immunological data are shown. Statistical significance of differences between the HIV negative group and all HIV-
infected adults was tested using Fisher’s exact test (for categorical variables) or Mann Whitney U test (for continuous variables). { Data on S. pneumoniae carriage are
missing for some patients for technical reasons.
doi:10.1371/journal.pone.0078592.t001
Figure 1. Loss of resting-memory B-cells and overrepresentation of apoptosis-prone mature-activated B-cells occurs early in HIV
infection. Percentages of circulating (A) mature naı¨ve (CD19+ CD102 CD272 CD21hi) (B) resting memory (CD19+ CD27+ CD21hi) (C) mature activated
(CD19+ CD21lo CD102) and (D) immature transitional (CD19+ CD10+ CD272) B-cells measured using flow cytometry in HIV2 (n = 44), HIV+ .350
(n = 16) and HIV+ #350 (n = 24) adults. Horizontal bars represent median values. Statistical significance of differences between groups was assessed
using the Mann Whitney U test.
doi:10.1371/journal.pone.0078592.g001
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Figure 2. IgM memory B-cells are depleted while isotype-switched memory B-cells are maintained in HIV-infected Malawian adults.
(A) IgM memory B-cells (CD19+ CD27+ IgD+) absolute numbers, (B) percentages and (C) isotype-switched memory B-cell (CD19+ CD27+ IgD2)
numbers, (D) percentages in the circulation of HIV2 controls (n = 44), HIV+ .350 (n = 16) and HIV+ #350 (n = 24) adult. Horizontal bars represent
medium values. Statistical significance of differences between groups was assessed using the Mann Whitney U test.
doi:10.1371/journal.pone.0078592.g002
Figure 3. Correlation between circulating IgM memory B-cells and CD4+ T-cells. (A) Scatter plots showing absolute IgM memory B-cell
numbers & CD4+ T-cell counts and (B) % IgM memory B-cells & CD4+ T-cells measured using flow cytometry. The association between the two
parameters (IgM memory B-cells and CD4 counts) was determined by Spearman’s correlation using Stata (Version 10). Each point represents the
result from one subject. rs is the Spearman rank correlation coefficient.
doi:10.1371/journal.pone.0078592.g003
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of these cells. More than twice the number of antigen-specific
memory B-cells were found in the blood of HIV2 adults for all
four antigens (pneumococcal surface protein A (PspA), pneumo-
coccal surface adhesion A (PsaA), pneumolysin (Ply) and choline
binding protein A (CbpA)), than in HIV+ adults. These results
reached statistical significance for PspA and PsaA (P = 0.02,
P = 0.0002 respectively; Figure 4). On stratifying HIV+ adults into
two groups based on their CD4+ counts, depletion of PspA and
PsaA-specific memory B-cells was observed even in the group with
relatively preserved CD4+ counts (Group I), results reaching
statistical significance for only PsaA. However, the differences
were more extensive in the HIV+ group with CD4+ counts below
350 (Group II, Figure 4).
Discussion
Progressive dysfunction of the humoral immune response is one
of the hallmarks of HIV infection. Defects in B-cell immunity have
been identified in HIV-infected adults with chronic infection or
advanced disease in which apoptosis-prone immature transitional
B-cells and mature activated B-cells are overrepresented [8,10]. In
line with these and our previous studies of HIV-infected Malawian
children [5], we have found loss of total, naı¨ve and resting memory
B-cells together with an overrepresentation of apoptosis-prone B-
cell subsets (immature transitional and mature activated B-cells),
even among HIV-infected Malawian adults with relatively
preserved CD4+ T-cell counts. These changes were associated
with IgM memory B-cell depletion but not isotype-switched IgG
memory B-cells, and impairment of specific B-cell memory to a
range of pneumococcal proteins. Thus, taken together these data
suggest that in minimally symptomatic HIV-infected individuals,
the B-cell compartment is profoundly disrupted with a consider-
able shift in the distribution of normal B-cell subsets in the blood.
Although serotype-specific anticapsular antibodies are protec-
tive when induced by vaccination, naturally acquired antibodies
against subcapsular pneumococcal proteins such as PspA, PsaA,
Figure 4. Loss of specific isotype-switched IgG memory B-cells in HIV-infected adults to pneumococcal protein antigens. Using an
ELISPOT assay, following the expansion of memory B-cells with a cocktail of mitogens (SAC, PWM & CpG DNA) for six days, (A) Pneumococcal surface
protein A (PspA), (B) Pneumococcal surface adhesion A (PsaA), (C) Pneumolysin (Ply), and (D) Choline binding protein A (CbpA) specific IgG antibody
secreting cells (ASC) were enumerated in HIV2 controls (n = 36), HIV+ .350 (n = 16) and HIV+ #350 (n = 21) adults. Memory B-cell responses were
expressed as numbers of ASC per million cultured PBMC seeded on the ELISPOT well. Each dot represents a mean of triplicates. Horizontal bars
represent median values. Statistical significance of differences between groups was assessed using the Man Whitney U test.
doi:10.1371/journal.pone.0078592.g004
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Ply and CbpA, and interferon-c and IL-17-producing CD4 T-cells
are thought to be more important in natural immunity [19,20,21].
Impairment of B-cell memory to these key pneumococcal proteins
observed in our HIV infected cohort, implicates defects in this B-
cell immunity in IPD causation. We speculate that the impact of
HIV on the immune memory responses to PspA and PsaA versus
CbpA and Ply could amongst other things be due to, immuno-
genicity, differential T-cell defects and antigen expression during
colonisation. It appears that at this stage of HIV-infection,
pneumococcal colonisation is controlled, however, the ability to
control nasopharyngeal carriage of the pneumococcus deteriorates
as HIV disease progresses and does not reverse with ART therapy
[7]. This highlights the need to study the functionality and
duration of immune memory to novel candidate pneumococcal
protein vaccine antigens in immunocompromised populations in
order to optimize their effectiveness.
The origin and functionality of CD19+ CD27+ IgM+ IgD+
memory B-cells remain contentious. Based on their expression of
the memory B-cell marker CD27 and the presence of IGV genes
exhibiting few somatic mutations, (classically restricted to post-
germinal center memory B-cells), these lymphocytes were initially
thought to be non-switched memory IgM+ IgD+ B-cells [22].
Alternatively, it is now more widely believed that this IgM memory
B-cell subset is germinal center-independent, emerging from the
splenic marginal zone with a prediversified immunoglobulin
repertoire. Following Toll-like receptor (TLR)-engagement, they
are involved in the thymus-independent production of natural
antibodies, the first line defence against encapsulated bacteria
[22,23,24]. Indeed some studies have shown a strong correlation
between the loss of IgM memory B-cells and reduced antibody
levels to pneumococcal polysaccharides [24,25]. In studies of
polysaccharide vaccine antigens [26], we have found that antigen-
specific IgM memory B-cells are not readily distinguishable from a
large non-specific antibody response using the same polyclonal
stimulated ELISPOT approach, which generates IgM antibodies
to both vaccine and non-vaccine antigens regardless of vaccination
status (unpublished data).
The exact mechanisms involved in the B-cell immunodeficiency
observed in our minimally symptomatic HIV-infected adults are
uncertain. In healthy individuals, following exposure to a T-cell
dependent antigen, naı¨ve B-cells can differentiate either into short-
lived immunoglobulin secreting cells, long-lived plasma cells or
memory B-cells [27,28]. Our data do not exclude a functional T-
cell defect or its effect on B-cell immunity. We have previously
shown that asymptomatic HIV-infected adults show considerable
T-cell immune dysregulation with impaired upregulation of the
co-receptor CD154 [6]. We have also demonstrated that despite
immune reconstitution with ART, CD4-mediated immunity is not
fully restored [7]. In the present manuscript we show that even
though no decrease was observed in isotype-switched IgG memory
B-cell proportions and numbers in Malawian HIV-infected adults,
there was a functional impairment of these cells. Whether the
functional impairment results from the direct effects of HIV on the
B-cell pool (e.g. from the transfer of negative factor from HIV-
infected macrophages to B-cells [29]) or the indirect effects of
impaired T follicular helper cells [30] remains to be determined. A
possible confounding factor in our experiments may be lack of
CD4 T-cell help in our PBMC cultures, amongst other things.
In conclusion, these data suggest that early in the course of
disease progression, horizontally acquired HIV infection in adults
primarily affects B-cell maturation after leaving the bone marrow,
potentially leading to impairment of humoral responses to
extracellular pathogens such as the pneumococcus and suscepti-
bility to invasive disease. These defects appear to affect both T-cell
independent and T-cell dependent B-cell-mediated immune
defence against invasive pneumococcal disease. ART reduces
polyclonal B-cell activation and normalizes the skewing of B-cell
subsets [31]. How the early institution of ART in such individuals’
impacts on this B-cell immune defect requires further investiga-
tion.
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